Is phytonadione a form of vitamin K?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, phytonadione is vitamin K1.

Phytonadione is the pharmaceutical name for vitamin K1 (phylloquinone), one of the naturally occurring forms of vitamin K used therapeutically to treat vitamin K deficiency and reverse anticoagulation. 1, 2

Understanding Vitamin K Forms

The vitamin K family consists of several distinct compounds 1:

  • Vitamin K1 (phylloquinone/phytonadione): Plant-derived, the form used in pharmaceutical preparations
  • Vitamin K2 (menaquinones): Synthesized by human intestinal bacteria
  • Vitamin K3 (menadione): A synthetic provitamin requiring conversion to menaquinone-4 to be active; no longer available due to toxicity 3

Clinical Significance

Phytonadione is FDA-approved for treating coagulation disorders due to vitamin K deficiency or interference with vitamin K activity, including 2:

  • Anticoagulant-induced prothrombin deficiency (warfarin/coumarin reversal)
  • Hypoprothrombinemia secondary to antibacterial therapy
  • Malabsorption conditions (celiac disease, cystic fibrosis, short bowel syndrome, biliary obstruction)
  • Drug-induced hypoprothrombinemia from salicylates or other interfering medications

Mechanism of Action

Phytonadione serves as a cofactor for γ-carboxylation of vitamin K-dependent proteins, including coagulation factors II, VII, IX, and X, as well as proteins C, S, M, and Z 1, 4. When warfarin blocks the vitamin K epoxide reductase enzyme, phytonadione can bypass this blockade to restore normal coagulation 4.

Important Clinical Considerations

Rare but serious anaphylactoid reactions with bronchospasm and cardiac arrest have been reported with IV phytonadione administration 1, 3. This risk necessitates careful monitoring during intravenous administration.

The terms "phytonadione," "vitamin K1," and "phylloquinone" are used interchangeably in clinical practice and medical literature, all referring to the same therapeutic compound with the molecular formula C₃₁H₄₆O₂ 2.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.